Hyperbaric Oxygen: An Important Treatment Modality in Severe Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation/Hiperbarik Oksijen: Allojeneik Hematopoietik Kok Hucre Nakli Sonrasi Gelisen Agir Hemorajik Sistit Olgularinda Onemli Bir Tedavi Secenegi (Research Article) (Report) Hyperbaric Oxygen: An Important Treatment Modality in Severe Hemorrhagic Cystitis After Allogeneic Hematopoietic Stem Cell Transplantation/Hiperbarik Oksijen: Allojeneik Hematopoietik Kok Hucre Nakli Sonrasi Gelisen Agir Hemorajik Sistit Olgularinda Onemli Bir Tedavi Secenegi (Research Article) (Report)
2009
Acute Myeloblastic Leukemia-Associated Marfan Syndrome and Davidoff-Dyke-Masson Syndrome: A Case Report/Akut Myeloblastik Losemi Ile Marfan Sendromu Ve Davidoff-Dyke-Masson Sendromu Birlikteligi: Bir Olgu Sunumu (Case Study) Acute Myeloblastic Leukemia-Associated Marfan Syndrome and Davidoff-Dyke-Masson Syndrome: A Case Report/Akut Myeloblastik Losemi Ile Marfan Sendromu Ve Davidoff-Dyke-Masson Sendromu Birlikteligi: Bir Olgu Sunumu (Case Study)
2008
Some Hematological Parameters and the Prognostic Value of CD4, CD8 and Total Lymphocyte Counts and CD4/CD8 Cell Count Ratio in Healthy HIV Sero-Negative, Healthy HIV Sero-Positive and AIDS Subjects in Port Harcourt, Nigeria/Nijerya'da (Port Harcourt) Saglikli HIV Seronegatif, Saglikli HIV Seropozitif Ve AIDS Hastasi Olgularda CD4, CD8 Ve Toplam Lenfosit Sayimi Ve CD4/CD8 ... (Research Article) (Cluster of Differentiation) (Human Immunodeficiency Virus) (Acquired Immunodeficiency Syndrome) (Report) Some Hematological Parameters and the Prognostic Value of CD4, CD8 and Total Lymphocyte Counts and CD4/CD8 Cell Count Ratio in Healthy HIV Sero-Negative, Healthy HIV Sero-Positive and AIDS Subjects in Port Harcourt, Nigeria/Nijerya'da (Port Harcourt) Saglikli HIV Seronegatif, Saglikli HIV Seropozitif Ve AIDS Hastasi Olgularda CD4, CD8 Ve Toplam Lenfosit Sayimi Ve CD4/CD8 ... (Research Article) (Cluster of Differentiation) (Human Immunodeficiency Virus) (Acquired Immunodeficiency Syndrome) (Report)
2008
Fertility Preservation in Females with Malignant Disease-1: Causes, Clinical Needs and Indications/ Malignitesi Olan Kadinlarda Dogurganligin Korunmasi-1: Nedenler, Klinik Gereksinimler Ve Endikasyonlar (Report) Fertility Preservation in Females with Malignant Disease-1: Causes, Clinical Needs and Indications/ Malignitesi Olan Kadinlarda Dogurganligin Korunmasi-1: Nedenler, Klinik Gereksinimler Ve Endikasyonlar (Report)
2009
Immunohematological Characteristics of Nigerian Sickle Cell Disease Patients with Osteomyelitis/ Osteomiyeliti Olan Nijeryali Orak Hucre Hastaligina Sahip Kisilerin Immunohematolojik Ozellikleri (Research Article) (Report) Immunohematological Characteristics of Nigerian Sickle Cell Disease Patients with Osteomyelitis/ Osteomiyeliti Olan Nijeryali Orak Hucre Hastaligina Sahip Kisilerin Immunohematolojik Ozellikleri (Research Article) (Report)
2008
Association of FXII 5'UTR 46CT Polymorphism with FXII Activity and Risk of Thrombotic Disease/Fxii 5'UTR 46CT Polimorfizmi Ile FXII Aktivitesi Ve Trombotik Hastalik Riskinin Iliskisi (Research Article) (Report) Association of FXII 5'UTR 46CT Polymorphism with FXII Activity and Risk of Thrombotic Disease/Fxii 5'UTR 46CT Polimorfizmi Ile FXII Aktivitesi Ve Trombotik Hastalik Riskinin Iliskisi (Research Article) (Report)
2010